Advanced search
Publication Cover
Biologics: Targets and Therapy Volume 14, 2020 - Issue
Submit an article Journal homepage
118
Views
3
CrossRef citations to date
0
Altmetric
Review

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease

Eman Al Sulais1 Department of Medicine, Royal Commission Hospital, Jubail, Saudi ArabiaCorrespondence[email protected]
&
Turki AlAmeel2 Department of Medicine, King Fahad Specialist Hospital, Dammam, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0003-0147-7540
ORCID Icon
Pages 1-11 | Published online: 10 Jan 2020

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ogugua Ndili Obi, Elyse E. Lower & Robert P. Baughman. (2021) Biologic and advanced immunomodulating therapeutic options for sarcoidosis: a clinical update. Expert Review of Clinical Pharmacology 14:2, pages 179-210.
Read now

Articles from other publishers (2)

Alexander Keith Turbayne & Miles Patrick Sparrow. (2022) Low-Dose Azathioprine in Combination with Allopurinol: The Past, Present and Future of This Useful Duo. Digestive Diseases and Sciences 67:12, pages 5382-5391.
Crossref
Eduardo Mysler, Valderilio Feijó Azevedo, Silvio Danese, Daniel Alvarez, Noriko Iikuni, Beverly Ingram, Markus Mueller & Laurent Peyrin-Biroulet. (2021) Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?. Drugs 81:16, pages 1859-1879.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.